"no one has anything to say about how H2 FY17 ebitda is actually lower than that of FY16?"
Here are the figures for EBITDA over the past 4 halves:
2016
DH EBITDA: $500,000
JH EBITDA: $1.6 million
---------------
2017
DH EBITDA: $1.2 million
JH EBITDA: $1.4 million
As you can see, EBITDA was abnormally low for the 2016 DH ($511,000). This was due mainly to timing differences from Master Franchise and Franchise sales. It was stated in the FY16 half year report that the shortfall would be corrected by the year end as it got added to the second half earnings.
This explains the abnormally large EBITDA of $1.6 million for 2016 JH.
Given this year's sales were not as lumpy as last year's, I believe this explains the relatively poorer second half EBITDA performance. It's also why I think assessing earnings performance on the whole year is more instructive than comparing halves.
- Forums
- ASX - By Stock
- KME
- Ann: Appendix 4E and 30 June 2017 Annual Report
Ann: Appendix 4E and 30 June 2017 Annual Report, page-9
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KME (ASX) to my watchlist
(20min delay)
|
|||||
Last
50.0¢ |
Change
-0.020(3.85%) |
Mkt cap ! $27.00M |
Open | High | Low | Value | Volume |
51.0¢ | 51.0¢ | 50.0¢ | $7.731K | 15.33K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6589 | 50.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
51.0¢ | 999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 439 | 0.915 |
1 | 7582 | 0.910 |
1 | 5524 | 0.905 |
2 | 20484 | 0.900 |
1 | 1149 | 0.870 |
Price($) | Vol. | No. |
---|---|---|
0.945 | 557 | 1 |
0.950 | 12474 | 2 |
0.960 | 53883 | 2 |
0.970 | 20668 | 1 |
0.980 | 27357 | 2 |
Last trade - 14.55pm 02/12/2024 (20 minute delay) ? |
Featured News
KME (ASX) Chart |